Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Professor Keith Channon will be replaced as Director of the Oxford BRC by Professor Helen McShane, of the Jenner Institute.

Prof McShane said “It is a great honour to have been appointed to lead the Oxford BRC and am very excited about taking up this pivotal role for medical research in Oxford".

Read the full article

Similar stories

R21/Matrix-M malaria vaccine receives WHO recommendation for use

The World Health Organization’s Strategic Advisory Group of Experts (SAGE) and Malaria Policy Advisory Group (MPAG) have recommended Oxford’s R21/Matrix-M™ malaria vaccine for use. The highly effective vaccine developed by the Jenner Institute and the Serum Institute of India has demonstrated high efficacy with a reassuring safety profile.